Dyne Therapeutics DYN
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 38th percentile, 5-year average -4.7x
Around its usual level · 59th percentile, 5-year average 4.2x
#3936 of 5330 stocks by PB (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.45 | – | 4.18 | 59% (pricier than usual) | #3936 of 5330 (1 = cheapest) |
| PE | -4.74 | -4.22 | -4.67 | 38% (cheaper than usual) | – |
| PS | – | 122.07 | 0.01 | – | – |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on DYN.
Sign in to join the discussion.